Anson Funds Management LP Purchases New Shares in Applied DNA Sciences Inc $APDN

Anson Funds Management LP bought a new position in shares of Applied DNA Sciences Inc (NASDAQ:APDN) in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 210,054 shares of the technology company’s stock, valued at approximately $349,000. Anson Funds Management LP owned approximately 19.03% of Applied DNA Sciences as of its most recent SEC filing.

Separately, Millennium Management LLC purchased a new position in Applied DNA Sciences in the 4th quarter valued at $28,000. 22.22% of the stock is owned by institutional investors.

Applied DNA Sciences Stock Performance

Shares of APDN stock opened at $2.60 on Thursday. Applied DNA Sciences Inc has a one year low of $2.13 and a one year high of $1,410.00. The firm’s 50 day moving average price is $4.17 and its 200-day moving average price is $18.10. The firm has a market cap of $3.35 million, a P/E ratio of 0.00 and a beta of 0.09.

Applied DNA Sciences (NASDAQ:APDN) last posted its quarterly earnings results on Thursday, August 14th. The technology company reported ($34.00) EPS for the quarter, topping the consensus estimate of ($37.50) by $3.50. The business had revenue of $0.30 million during the quarter, compared to the consensus estimate of $1.28 million. Applied DNA Sciences had a negative net margin of 399.91% and a negative return on equity of 136.17%. As a group, research analysts predict that Applied DNA Sciences Inc will post -0.87 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Separately, Wall Street Zen cut Applied DNA Sciences from a “hold” rating to a “sell” rating in a report on Thursday, May 22nd.

Applied DNA Sciences Profile

Applied DNA Sciences, Inc, a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. It operates through three segments: Therapeutic DNA Production Services; MDx Testing Services; and DNA Tagging and Security Products and Services.